Shanghai-based Abbisko Therapeutics Co., Ltd. and Sichuan Huiyu Pharmaceutical Co., Ltd. have become the latest Chinese biopharmaceutical companies to go public, maintaining the strong fundraising momentum in the sector in the country.
Abbisko listed on the Hong Kong Stock Exchange on 13 October to raise HKD1.8bn ($225.6m) by selling 140.7 million new...